超越BCMA:在多发性骨髓瘤中,下一波的CAR T细胞治疗
Kevin Miller1, Hamza Hashmi1, Sridevi Rajeeve1
1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Frontiers in oncology
|May 27, 2024
概括
化学抗原受体 (CAR) T 细胞疗法对多发性骨髓瘤具有前景. 除了BCMA之外,正在探索新的CAR T细胞点,以克服治疗耐药性并改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 细胞疗法细胞疗法
背景情况:
- 化学抗原受体 (CAR) T细胞疗法已经彻底改变了多发性骨髓瘤治疗.
- 目前FDA批准的CAR T疗法向B细胞成熟抗原 (BCMA),导致初始反应但经常复发.
- 对抗BCMA CAR T细胞疗法的获得性耐药性需要探索替代点.
研究的目的:
- 审查新出现的CAR T细胞点,用于BCMA以外的多发性骨髓瘤.
- 总结关于新型CAR T细胞标的临床前和早期临床数据.
- 讨论这些新目标在克服治疗耐药性的潜力.
主要方法:
- 临床前研究和早期临床试验的文献综述.
- 对CAR T细胞治疗的新型抗原标数据的分析.
- 综合关于超越BCMA的CAR T细胞策略的信息.
主要成果:
- 一些新的点,包括G蛋白结合受体类C组5成员D (GPRC5D),信号淋巴细胞激活分子家族成员7 (SLAMF7) 和CD38,正在调查中.
- 针对这些新型抗原的CAR T细胞在临床前和临床早期环境中显示出有前途.
- 正在探索涉及抗BCMA和新目标的组合策略.
结论:
- 超越BCMA的新型CAR T细胞点对于解决多发性髓瘤复发和耐药性的关键.
- 像GPRC5D,SLAMF7和CD38这样的新兴目标代表着有前途的治疗途径.
- 这些新型CAR T细胞疗法的进一步临床开发是有必要的,以改善患者的治疗结果.
相关概念视频
Tumor Immunotherapy
515
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
515
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)

